Goodrx Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
GoodRx Holdings, Inc. has filed a definitive proxy statement with the SEC regarding its FY24 activities.
NASDAQ
GoodRx Holdings will hold its annual stockholders meeting virtually on June 3, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
GoodRx Holdings, Inc. has appointed Simon Patterson to its Board of Directors, effective immediately, following the resignation of Adam Karol in March 2024.
NASDAQ
GoodRx Holdings, Inc. has filed a definitive proxy statement with the SEC regarding its FY23 activities.
NASDAQ
GoodRx Holdings will hold its annual stockholders meeting virtually on June 6, 2024, to vote on director elections, auditor ratification, and executive compensation.